Xcellerant Ventures
  • Portfolio
  • Team
  • About
  • Invest
  • News
  • Contact
Select Page
New Data from Immunotherapy Quality of Life Study Accepted for Two Abstracts at 2023 ASCO

New Data from Immunotherapy Quality of Life Study Accepted for Two Abstracts at 2023 ASCO

by Xcellerant Ventures | Jun 2, 2023 | Portfolio Company News

Content origionally on TTI’s website: https://tti.care/new-data-from-immunotherapy-quality-of-life-study-accepted-for-two-abstracts-at-2023-asco/ — Treatment Technologies & Insights’ (TTI) ePRO app solution, Wave Health, enabled innovative approach to...
Health App That Tracks Response to Diseases Rated No. 1 by Cedars-Sinai Medical Center

Health App That Tracks Response to Diseases Rated No. 1 by Cedars-Sinai Medical Center

by Xcellerant Ventures | Dec 15, 2021 | Portfolio Company News

Content origionally posted on The EPOCH Times: https://www.theepochtimes.com/us/health-app-that-tracks-response-to-diseases-rated-no-1-by-cedars-sinai-medical-center-4159309?welcomeuser=1 A unique health app that allows patients to track how treatments, medications,...
Treatment Technologies & Insights, Inc (TTI) Launches Free New Health App Putting Artificial Intelligence In The Hands Of Chronic Illness Patients

Treatment Technologies & Insights, Inc (TTI) Launches Free New Health App Putting Artificial Intelligence In The Hands Of Chronic Illness Patients

by Xcellerant Ventures | Oct 4, 2019 | Portfolio Company News

Content origionally posted on PR Newswire: https://www.prnewswire.com/news-releases/treatment-technologies–insights-inc-tti-launches-free-new-health-app-putting-artificial-intelligence-in-the-hands-of-chronic-illness-patients-300931040.html LOS ANGELES, Oct. 4,...
Next Entries »

Recent Posts

  • TruLite Health Partners with Lee Health to Elevate Health Equity Strategy
  • TruLite Health Selected for Microsoft Pegasus Program
  • Xcellerant Ventures Leads DeepLook Medical’s Series A Round
  • DeepLook Medical’s DL Precise™ improved the performance of the breast imaging department with 12% favorable change in recall rates
  • Feasibility Study Evaluates Potential of Digital Health Platform to Help Patients Manage Prostate Cancer Symptoms

Recent Comments

No comments to show.
  • Portfolio
  • Team
  • About
  • Invest
  • News
  • Contact
  • Privacy Policy
© Xcellerant Ventures 2023